Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin production to maintain blood sugar levels. Scientists have thought that this ...

Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...

Beta cells (marked in green) in the pancreas are organized in structures termed islets. In most adults, it was found that a subset become senescent and display the marker p16, shown here in red. The ...

BOSTON--(BUSINESS WIRE)--Porosome Therapeutics, Inc. (Porosome Therapeutics) has announced a new and distinctive therapy for Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) targeting the insulin ...

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

Transplanting human gastric organoids engineered to release insulin in diabetic mice reduced hyperglycemia, offering a therapeutic avenue for type 1 diabetes. Researchers had previously reprogrammed ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide. Subscribe to our ...

Adults with insulin-deficient type 2 diabetes had a decrease in HbA1c that was maintained for 1 year after receiving a ...

The gene BHLHE40 disrupts insulin secretion in hyperglycemia-induced hypoxic conditions, which could inform drug development for type 2 diabetes Type 2 diabetes (T2D) is a chronic metabolic disorder ...